Exoxemis
Pre-clinicalExoxemis has completed a placebo controlled, randomized, international, Pivotal, Phase III, human clinical trial with 250 human subjects in each arm, at 25 U.S. and 5 Israeli sites. This study provides direct evidence that Zempia® is safe for use in open wounds—it does not interfere with normal wound healing.
Founded
2014
Focus
Drug Delivery
About
Exoxemis has completed a placebo controlled, randomized, international, Pivotal, Phase III, human clinical trial with 250 human subjects in each arm, at 25 U.S. and 5 Israeli sites. This study provides direct evidence that Zempia® is safe for use in open wounds—it does not interfere with normal wound healing.
Company Info
TypePrivate
Founded2014
LocationLittle Rock, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile